NYSE:CRL - Charles River Laboratories Intl. Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $129.90 +1.46 (+1.14 %) (As of 05/24/2019 04:00 PM ET)Previous Close$129.90Today's Range$129.10 - $130.9252-Week Range$103.00 - $149.07Volume199,164 shsAverage Volume396,164 shsMarket Capitalization$6.33 billionP/E Ratio21.54Dividend YieldN/ABeta0.99 ProfileAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Charles River Laboratories Intl. (NYSE:CRL) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.15 Wall Street analysts have issued ratings and price targets for Charles River Laboratories Intl. in the last 12 months. Their average twelve-month price target is $144.8462, suggesting that the stock has a possible upside of 11.51%. The high price target for CRL is $162.00 and the low price target for CRL is $125.00. There are currently 5 hold ratings and 10 buy ratings for the stock, resulting in a consensus rating of "Buy."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: BuyBuyBuyBuyConsensus Rating Score: 2.672.642.642.60Ratings Breakdown: 0 Sell Rating(s)5 Hold Rating(s)10 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)5 Hold Rating(s)9 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)5 Hold Rating(s)9 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)6 Hold Rating(s)9 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $144.8462$143.5833$139.00$131.4667Price Target Upside: 11.51% upside1.94% downside0.85% downside3.88% downsideCharles River Laboratories Intl. (NYSE:CRL) Consensus Price Target History Charles River Laboratories Intl. (NYSE:CRL) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails4/30/2019Evercore ISIReiterated RatingOutperform ➝ Outperform$160.00Low4/2/2019Wolfe ResearchInitiated CoverageMarket PerformMedium3/18/2019BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$135.00 ➝ $145.00Medium3/11/2019KeyCorpBoost Price TargetOverweight ➝ Overweight$140.00 ➝ $151.00Low2/14/2019SunTrust BanksBoost Price TargetPositive ➝ Buy$151.00Low2/14/2019Jefferies Financial GroupReiterated RatingBuy$162.00Low12/14/2018Deutsche BankInitiated CoverageBuy ➝ BuyLow12/4/2018Raymond JamesReiterated RatingBuy$150.00Low12/3/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$112.00 ➝ $136.00Low11/8/2018Robert W. BairdBoost Price TargetOutperform ➝ Outperform$144.00 ➝ $148.00Medium11/7/2018Royal Bank of CanadaSet Price TargetOutperform ➝ Buy$131.00 ➝ $147.00N/A10/9/2018UBS GroupInitiated CoverageNeutral ➝ Neutral$140.00Low9/25/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$121.00 ➝ $128.00High8/27/2018ArgusBoost Price TargetBuy ➝ Buy$125.00 ➝ $140.00Low7/16/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$120.00 ➝ $125.00Low4/20/2018Mitsubishi UFJ Financial GroupInitiated CoverageNeutral$115.00Low2/14/2018JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$110.00 ➝ $120.00Medium6/28/2017CitigroupReiterated RatingNeutral$91.00 ➝ $104.00Low(Data available from 5/25/2017 forward) This page was last updated on 5/25/2019 by MarketBeat.com StaffFeatured Article: Trading Stocks - What are percentage gainers? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.